하나제약, 이사회 재편 후 첫 스텝…삼진제약 지분 청산

Hana Pharm's exit from Samjin Pharm marks a strategic shift toward internal growth through CMO expansion and P-CAB drug development. The recent board reorganization suggests a significant change in management priorities and potential shifts in corporate governance following leadership transitions within the founding family.